supp.fit

Vanadium

6 benefits mapped to clinical evidence across supplements.

Dose per serving from products

1,309 products in our catalogue print how much Vanadium a serving holds.

Most common: 5 mcg to 10 mcg, 30% of 1,309 products.

Dose per servingProducts
1 mcg or less
10
1 mcg to 2.5 mcg
65
2.5 mcg to 5 mcg
44
5 mcg to 10 mcg
389
10 mcg to 25 mcg
154
25 mcg to 50 mcg
207
50 mcg to 100 mcg
148
100 mcg to 250 mcg
119
250 mcg to 500 mcg
35
500 mcg to 1 mg
46
1 mg to 2.5 mg
27
over 2.5 mg
65

Benefit Evidence

Vanadium↑; eGFR↓

Glucose↓, insulin genes↓

80 people

Lower glucose; better insulin sensitivity

↓ glucose AUC

44 people

Better glucose control

Less insulin resistance

44 people

NFκB/MAPK↓

Insulin signaling↓

44 people

Lower glucose, HbA1c

↓MAPK/PTP1B/NFκB expression

44 people

Better glucose, weight, ~0.9 mg V/day

Lower insulin resistance, gene expression

44 people

Research sources

Cell health (2)
  1. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    PubMed ID: 36826713

    Human trial showed decreases in insulin-signaling and inflammatory gene expression (MAPK, PTP1B, NFκB) after vanadium supplementation.

  2. A cross-sectional study measuring vanadium and chromium levels in paediatric patients with CKD

    PubMed ID: 28592575

    CKD children had frequently elevated plasma vanadium (cellular exposure/accumulation relevance and potential toxicity concern).

Blood sugar (1)
  1. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    PubMed ID: 36826713

    RCT in T2DM: vanadium-enriched yeast produced modest but significant improvements in glycemic control and insulin-related gene expression.

Energy & Fatigue (1)
  1. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    PubMed ID: 36826713

    Improved insulin signaling and metabolic measures in T2DM imply enhanced energy metabolism with vanadium-enriched yeast.

Inflammation (1)
  1. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    PubMed ID: 36826713

    Vanadium-enriched yeast in T2DM reduced NFκB expression, suggesting anti-inflammatory gene-level effects.

Metabolism (1)
  1. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    PubMed ID: 36826713

    Randomized T2DM trial with vanadium-enriched yeast improved glycemic and anthropometric measures and modulated insulin-signaling genes.

Weight management (1)
  1. Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    PubMed ID: 36826713

    T2DM trial reported decreased anthropometric indices after 12 weeks of vanadium-enriched yeast (supportive evidence).

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Vanadium

Search all

1707 products whose verified label declares Vanadium — not every bottle that mentions it in a title.